SK Chemical announced that they won a suit of banning infringement of the patent against Novartis

Published: 2014-05-19 15:02:19

Updated: 2014-05-19 15:02:19

On May 15, SK Chemical announced that they won a suit of banning infringement of the patent against Novartis.

The lawsuit is about 'Rivastigmine' which has efficacy in treatment of dementia, and

'Exelon patch' which put this material in a patch form. SK chemical was developing 'SID710 patch' which is not just generic of Exelon patch, but applied differentiated technology, based on their devel...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.